These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3117086)

  • 1. Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEA.
    Halila H; Huhtala ML; Haglund C; Nordling S; Stenman UH
    Br J Cancer; 1987 Aug; 56(2):153-6. PubMed ID: 3117086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated antigen CA 195 in patients with mucinous ovarian tumours: a comparative analysis with CEA, TATI and CA 125 in serum specimens and cyst fluids.
    de Bruijn HW; ten Hoor KA; Boonstra H; Marrink J; Krans M; Aalders JG
    Tumour Biol; 1993; 14(2):105-15. PubMed ID: 8392219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour-associated trypsin inhibitor (TATI) in ovarian cancer.
    Halila H; Lehtovirta P; Stenman UH
    Br J Cancer; 1988 Mar; 57(3):304-7. PubMed ID: 3162682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours.
    Mogensen O; Mogensen B; Jakobsen A
    Br J Cancer; 1990 Feb; 61(2):327-9. PubMed ID: 2310684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved specificity of the CA 125 enzyme immunoassay for ovarian carcinomas by use of the ratio of CA 125 to carcinoembryonic antigen.
    Wu JT; Miya T; Knight JA; Knight DP
    Clin Chem; 1988 Sep; 34(9):1853-7. PubMed ID: 2458203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CA 125 and carcinoembryonic antigen levels in cyst fluid, ascites and serum of patients with ovarian neoplasms.
    Harłozińska A; Bar JK; Gawlikowski W; Richter R; Cisło M
    Ann Chir Gynaecol; 1991; 80(4):368-75. PubMed ID: 1667567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncofetal antigens in ovarian cyst fluids.
    Kraly DH; Koh SH; Hay DL; Cauchi MN
    Gynecol Obstet Invest; 1984; 18(3):117-21. PubMed ID: 6208091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of CA125, carcinoembryonic antigen, and alpha-fetoprotein in ovarian cyst fluid: diagnostic adjunct to cytology.
    Pinto MM; Bernstein LH; Brogan DA; Parikh F; Lavy G
    Diagn Cytopathol; 1990; 6(3):160-3. PubMed ID: 1696873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma.
    Lewandrowski KB; Southern JF; Pins MR; Compton CC; Warshaw AL
    Ann Surg; 1993 Jan; 217(1):41-7. PubMed ID: 8424699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour-associated trypsin inhibitor and tumour-associated trypsin.
    Stenman UH
    Scand J Clin Lab Invest Suppl; 1990; 201():93-101. PubMed ID: 2244188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyst fluid tumor-associated trypsin inhibitor may be helpful in the differentiation of cystic pancreatic lesions.
    Räty S; Sand J; Alfthan H; Haglund C; Nordback I
    J Gastrointest Surg; 2004; 8(5):569-74. PubMed ID: 15239993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour-associated trypsin inhibitor (TATI) in patients with colorectal cancer: a comparison with CEA, CA 50 and CA 242.
    Pasanen P; Eskelinen M; Kulju A; Penttilä I; Janatuinen E; Alhava E
    Scand J Clin Lab Invest; 1995 Apr; 55(2):119-24. PubMed ID: 7667604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical use of gynaecologic tumour markers.
    Halila H; Alfthan H; Stenman UH
    Ann Chir Gynaecol; 1989; 78(1):65-70. PubMed ID: 2547331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of mucin-like carcinoma-associated antigen in the cyst fluid differentiates mucinous from nonmucinous pancreatic cysts.
    Sperti C; Pasquali C; Pedrazzoli S; Guolo P; Liessi G
    Am J Gastroenterol; 1997 Apr; 92(4):672-5. PubMed ID: 9128321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-associated trypsin inhibitor in the diagnosis of pancreatic carcinoma.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    J Cancer Res Clin Oncol; 1994; 120(8):494-7. PubMed ID: 8207049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the usefulness of serum measurements of CA 125, CA 50 and TATI in patients with malignant and benign gynecological pathology.
    Gadducci A; Ferdeghini M; Facchini V; Ceccarini T; Prontera C; Bianchi R; Fioretti P
    Eur J Gynaecol Oncol; 1990; 11(2):111-5. PubMed ID: 2379509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-associated trypsin inhibitor and cancer antigen 125 in pelvic masses.
    Mogensen O; Mogensen B; Jakobsen A
    Gynecol Oncol; 1990 Aug; 38(2):170-4. PubMed ID: 2167279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of cyst puncture in the differential diagnosis of benign ovarian tumours.
    Vercellini P; Oldani S; Felicetta I; Bramante T; Rognoni MT; Crosignani PG
    Hum Reprod; 1995 Jun; 10(6):1465-9. PubMed ID: 7593516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor markers CA 125, carcinoembryonic antigen and tumor-associated trypsin inhibitor in patients with cervical adenocarcinoma.
    Leminen A
    Gynecol Oncol; 1990 Dec; 39(3):358-63. PubMed ID: 2258083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyst fluid of ovarian cancer patients contains high concentrations of trypsinogen-2.
    Koivunen E; Itkonen O; Halila H; Stenman UH
    Cancer Res; 1990 Apr; 50(8):2375-8. PubMed ID: 2180568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.